Coral Laboratories recommends ₹2 dividend for FY26

0 min read     Updated on 30 May 2026, 11:17 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Coral Laboratories Limited recommended a final dividend of ₹2.00 per share, or 20%, for FY26. The dividend is subject to shareholder approval at the upcoming Annual General Meeting.

powered bylight_fuzz_icon
41708831

*this image is generated using AI for illustrative purposes only.

coral laboratories has recommended a final dividend of 20%, or ₹2 per share, for the financial year 2025-26. The dividend is based on a face value of ₹10 per share and is subject to the approval of shareholders at the ensuing Annual General Meeting. The recommendation was made during a Board meeting held on May 30, 2026.

The Board of Directors approved the proposal in accordance with Regulation 43 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The payout will be finalized only after receiving member approval at the company's Annual General Meeting.

Dividend Details

The following table outlines the key details of the recommended dividend:

Parameter Details
Dividend Type Final
Financial Year FY26
Dividend Rate 20%
Dividend per Share ₹2.00
Face Value per Share ₹10

The disclosure was submitted to BSE Limited on May 30, 2026, by Sushma Shashi Kadkade, Director & CFO of Coral Laboratories Limited.

Historical Stock Returns for Coral Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+0.70%+4.65%+16.23%-1.53%-38.50%-4.34%

How will this dividend payout impact Coral Laboratories' capital allocation plans for R&D and expansion in FY27?

What market reaction is anticipated regarding Coral Laboratories' stock price leading up to the record date?

Does this dividend signal confidence from the Board in the company's sustained cash flow generation amidst potential industry headwinds?

Coral Laboratories appoints cost auditor for FY27

1 min read     Updated on 30 May 2026, 10:55 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Coral Laboratories Limited has appointed M/s Aatish Dhattrak & Associates as its Cost Auditor for FY27, effective May 30, 2026. The Board approved the appointment following the Audit Committee's recommendation. The firm is unrelated to the company's directors.

powered bylight_fuzz_icon
41707488

*this image is generated using AI for illustrative purposes only.

Coral Laboratories Limited has appointed M/s Aatish Dhattrak & Associates as its Cost Auditor for the financial year 2026-2027. The appointment, effective from May 30, 2026, was approved by the Board of Directors based on the recommendation of the Audit Committee. This move ensures compliance with regulatory requirements governing cost audits for the upcoming fiscal year.

The decision was formalized during the Board meeting held on May 30, 2026. M/s Aatish Dhattrak & Associates, a partnership firm of Cost Accountants, brings extensive expertise in cost audit, accounts, audit, risk management, and project management. The firm holds a Firm Registration Number (FRN) of 101575.

Appointment Details

The company disclosed that there are no relationships between the newly appointed Cost Auditor and the directors of Coral Laboratories Limited. The appointment falls under the category of a new engagement rather than a change from a previous auditor.

Key Information

Detail Description
Name M/s Aatish Dhattrak & Associates (FRN: 101575)
Designation Cost Auditor
Reason for Change Appointment
Date of Appointment May 30, 2026
Tenure Financial Year 2026-2027
Relationship with Directors Not applicable

Historical Stock Returns for Coral Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+0.70%+4.65%+16.23%-1.53%-38.50%-4.34%

What specific cost control measures does Coral Laboratories plan to implement with the new auditor's expertise?

How will the appointment impact the company's operational efficiency and profit margins in FY 2026-2027?

Are there any upcoming regulatory changes that might influence the scope of cost audits for Coral Laboratories?

More News on Coral Laboratories

1 Year Returns:-38.50%